
By Kerry Sheridan Scientists say that the flu shot could also help protect your heart. ©F.C.G./Shutterstock.com WASHINGTON, August 13, 2014 (AFP) – Older people are likely to benefit from a high-dose flu vaccine to ward off the seasonal malaise, which can be particularly dangerous to those over 65, researchers said Wednesday. The findings in the New England Journal of Medicine are from the first randomized, controlled trial to compare high and standard doses of flu vaccine in older people. “Until this trial came out we didn’t know if it was going to be clinically better or not, and now we know it is better,” said lead author Keipp Talbot, assistant professor of medicine at Vanderbilt University. The study was funded by Sanofi Pasteur and compared the company’s Fluzone High-Dose inactivated influenza vaccine to the standard-dose Fluzone vaccine. The high-dose contains four times the amount of antigen as the standard dose. The high-dose flu vaccine was 24 percent more effective than the standard-dose vaccine in protecting those over 65 against influenza and its complications, which can include pneumonia and heart failure. It was also found to be safe and induced “significantly higher antibody responses” than the standard dose did. Side effects included greater arm soreness following the injection. The study involved nearly 32,000 people at 126 research centers in the United States and Canada. The flu causes tens of thousands of deaths each year and more than 200,000 hospitalizations, according to background information in the article. “These new data are important Read More …








